Cresco opened of four locations in New York and launched a delivery service for medical cannabis patients in the state’s New Hartford area.

Cresco Labs (CSE:CL,OTCQX:CRLBF) announced the opening of four dispensaries across New York as well as a home delivery service for medical cannabis patients in the state’s New Hartford area.

As quoted in the press release:

Patients can place orders for home delivery for a variety of products including vape pens and cartridges, topical creams, oral tinctures and capsules at Sunnyside.shop. Cresco plans to roll out its medical cannabis home delivery program to the three other communities with Sunnyside* locations in the coming months.
These dispensaries in the state of New York are the first stores to be rebranded under Cresco’s national retail brand on the East Coast. Cresco holds one of the 10 vertically integrated cannabis business licenses granted in the state by the New York State Department of Health. Each license gives the operator the right to operate one cultivation facility and four dispensaries in New York.

Click here to read the full press release.

cresco labs cse:cl new york otc:crlbf Cannabis Investing